article thumbnail

Axsome Aims for FDA Filing in Alzheimer’s Agitation Despite Mixed Bag of Phase 3 Data

MedCity News

Axsome Therapeutics aims to offer an alternative to Rexulti, a Lundbeck and Otsuka Pharmaceutical product that is the only FDA-approved Alzheimers agitation drug. The post Axsome Aims for FDA Filing in Alzheimers Agitation Despite Mixed Bag of Phase 3 Data appeared first on MedCity News.

FDA 289
article thumbnail

Red Sea Shipping Disruptions Don’t Have Pharma Companies Seeing Red Just Yet

MedCity News

Generic drugs are the pharmaceutical products mainly affected by the missile attacks disrupting shipping in the Red Sea. While the extra costs borne by drug companies aren’t causing an immediate spike in product prices, experts say they’ll eventually be factored into prices if the attacks become a long-term problem.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Astellas Drug Acquired in $5.9B Deal Wins FDA Approval in Vision-Loss Disorder

MedCity News

Izervay, a drug developed by Astellas Pharma subsidiary Iveric Bio, is now the second approved therapy for the degenerative vision-loss disorder geographic atrophy. The regulatory decision comes as safety concerns emerge around the first therapy for the disease, an Apellis Pharmaceuticals product.

article thumbnail

How Counterfeit Medicines Challenge Pharma Sales in Malaysia

Contrarian Sales Techniques

Imagine spending weeks building trust with a doctor or pharmacist, only to find out that counterfeit versions of your product are circulating in the market. It’s a reality for many of us in pharma sales in Malaysia. Why This Hits Close to Home for Pharma Reps As someone in pharma sales, this problem feels personal.

article thumbnail

Which Social Media Analytics Matter Most in Pharma Marketing

Pharma Marketing Network

To measure success and improve engagement, pharma marketing teams must focus on the right social media analytics. With increasing regulations, evolving digital trends, and shifting audience behaviors, pharma marketers need to analyze data that aligns with brand goals, compliance requirements, and engagement strategies.

Media 52
article thumbnail

5 Proven Social Media Marketing Strategies for Pharma Brands

Pharma Marketing Network

In the world of pharmaceutical marketing, social media marketing strategies are more than a trend; they’re a necessity. But with strict regulations and evolving consumer expectations, how do pharma brands navigate the digital landscape effectively? Pharma professionals should take the time to research and segment their audience.

Media 52
article thumbnail

FDA Approves BioMarin Pharma’s Gene Therapy, the First for Hemophilia A

MedCity News

The regulatory decision makes the BioMarin Pharmaceutical product the first gene therapy for this inherited bleeding disorder. The FDA approved Roctavian for treating hemophilia A.

FDA 263